PharMerica CORP: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $2.1B
- Net Income/Loss (FY2016)
- $21.6M
- Total Assets (FY2016)
- $1.3B
- Total Equity (FY2016)
- $544.2M
- Cash Flows from Operating Activities (FY2016)
- $30.8M
Source: PharMerica CORP 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
